You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...
Recently, fenfluramine appetite suppressants became widely used in the United States but were withdrawn in September 1997 because of concerns over adverse effects. Materials and methods ...
Data include the use of FINTEPLA® (fenfluramine)1 oral solution in seizures associated with Dravet syndrome and Lennox-Gastaut ...
We have updated this service so that members of the same organisation can now collaborate on a joint online response.
The serotonergic agent fenfluramine was removed from the market in 1997 after being linked to valvular heart disease. Phenylpropanolamine, a sympathomimetic compound subsequently associated with ...
Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left more money in people’s wallets. Lighter passengers are saving ...
A retrospective analysis on newborn screening for spinal muscular atrophy (SMA) provides further evidence for the benefits of early identification and treatment of the disease. A recent analysis ...
Lundbeck will buy Longboard Pharmaceuticals and its 5-HT 2C receptor agonist bexicaserin, which is currently in phase III development for seizures associated with Dravet syndrome. The deal, valued ...